Mohammad Makoseh

10PUBLICATIONS
34CO-AUTHORS
Process control and simulationPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 09, 2026
Point-of-Care Manufacturing of Anti-CD19.1-Chimeric Antigen Receptor-T Cells Using CliniMACS Prodigy: Real-World Experience From Jordan.

|May 29, 2026
Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

|Apr 01, 2026
Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

Mohammad Ma'koseh, Omar Shahin, Alaa Abufara

|Oct 29, 2025
Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices.

Mohammad Ma'koseh, Heba Farfoura, Mahmoud Abunasser

|Jan 25, 2025
The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.

Akram Al-Ibraheem, Ahmad Saad Abdlkadir, Nabil Hasasna

|May 11, 2024
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review.

Akram Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci

Pageof 2

Frequent Collaborators

5 joint publications

Hikmat Abdel-Razeq

4 joint publications

Akram Al-Ibraheem

3 joint publications

Zaid Abdelrahman

3 joint publications

Kamal Al-Rabi